3656 results for «225»

Filter By

3656 results

Taking the next step in the evolution of aortic regurgitation treatment

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Explore the latest in aortic regurgitation treatment, including a TAVI case with the Trilogy device, imaging challenges, and future advancements like CMR and guideline updates.

Taking the next step in the evolution of aortic regurgitation treatment

Aortic valve disease – Imaging strategies for optimal valve selection and outcomes in TAVI

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Dive into this in-depth session on aortic valve disease, covering essential imaging insights for selecting the ideal TAVI prosthesis, identifying risk markers for pacemaker implantation, and optimizing outcomes in complex cases. Learn how multi-modality imaging aids in diagnosing and managing bioprosthetic valve dysfunction, including detecting patient-prosthesis...

Imaging strategies for optimal valve selection and outcomes in TAVI

Mastering mitral valve disease: diagnosis, management, and intervention

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Dive into this comprehensive session on mitral valve disease, covering key aspects of diagnosis, classification, assessment, management, and patient selection for transcatheter intervention. Gain in-depth knowledge through real-world case studies and multidisciplinary team discussions, equipping you with essential skills to optimize patient care.

Mastering mitral valve disease: diagnosis, management, and intervention

Advancing imaging and intervention strategies for mitral valve disease

31 Jan 2025 – From PCR Imaging Valves Madrid 2025

Explore the latest imaging techniques for transcatheter mitral valve interventions, including patient screening, device selection, and strategies for challenging anatomies. Gain insights into TEER and transcatheter mitral valve replacement to optimize patient outcomes.

Advancing imaging and intervention strategies for mitral valve disease

Advancing the management of tricuspid valve disease: diagnosis, imaging, and intervention

01 Feb 2025 – From PCR Imaging Valves Madrid 2025

This session explores tricuspid valve disease, focusing on the determinants and severity of tricuspid regurgitation, right heart assessment, and available treatment options. Through case studies and expert discussions, learn about imaging techniques, the heart team approach, and best practices for selecting patients for transcatheter tricuspid valve...

Advancing the management of tricuspid valve disease

Advancing transcatheter solutions for tricuspid valve disease

01 Feb 2025 – From PCR Imaging Valves Madrid 2025

This session delves into the latest advancements in transcatheter tricuspid valve interventions, covering procedural considerations, patient selection, and imaging techniques. Explore case studies, strategies for tricuspid transcatheter edge-to-edge repair, and key criteria for valve replacement. Learn about managing failed T-TEER cases and the role of transcatheter...

Advancing transcatheter solutions for tricuspid valve disease

Navigating complexities in multivalvular heart disease: risk stratification, intervention timing, and advanced imaging

01 Feb 2025 – From PCR Imaging Valves Madrid 2025

This session explores the challenges of managing mixed and multiple valvular heart diseases, focusing on risk stratification, treatment decisions, and transcatheter intervention timing. Experts discuss assessing and treating aortic and mitral paravalvular leaks, as well as managing mitral annular calcification, using case studies to guide optimal...

Navigating complexities in multivalvular heart disease

Optimizing diagnosis and treatment in multivalvular heart disease

01 Feb 2025 – From PCR Imaging Valves Madrid 2025

This session explores the diagnostic challenges and treatment strategies for mixed and multiple valvular heart diseases. Through case scenarios, including aortic stenosis, regurgitation, and combined atrioventricular valve regurgitation, learn how to use imaging modalities to assess severity and determine optimal treatment timing.

Optimizing diagnosis and treatment in multivalvular heart disease

PCR Tricuspid Focus Group

21 Apr 2021

Discover an overview of the new initiative’s mission and five ongoing working groups

Introducing the PCR Tricuspid Focus Group

Coronary artery rupture in hybrid treatment

12 Apr 2024

Find out more about the step-by-step approach to effectively manage coronary artery rupture using prolonged balloon inflation.

Paul Gamboa

Author

Paul Gamboa
Coronary artery rupture in hybrid treatment

RIPCORD 2: does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain?

29 Aug 2021

Nicola Ryan presents a synthesis of this study which compares FFR-guided assessment of patients with chest pain with angiographic guidance alone, and which was presented by Nicholas Curzen (Southampton, USA) during the ESC Congress 2021.

Nicola Ryan

Author

Nicola Ryan
RIPCORD 2: does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain?

MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

01 Sep 2024

Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.

Yohei Ohno

Author

Yohei Ohno
MATTERHORN

Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry

17 Sep 2022

Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.

Elad Asher

Author

Elad Asher
Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry

BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

07 Nov 2022

Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.

This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...

Nicola Ryan

Author

Nicola Ryan
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Coronary OCT and CMR imaging to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries

29 Mar 2026

Nicola Ryan provides her take on the trial evaluating multi-modality imaging to determine underlying causes of MINOCA in women and men. The trial results were presented by Harmony R. Reynolds at ACC.26 in New Orleans and simultaneously published in Circulation.

Nicola Ryan

Author

Nicola Ryan
Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine sex differences in underlying causes of myocardial infarction with no obstructive coronary arteries

The top ten impactful papers from 2025 on tricuspid intervention we almost missed

13 Jan 2026

Transcatheter interventions have rapidly reshaped the management of tricuspid valve disease, with landmark trials establishing feasibility and early clinical benefit.

Beyond these pivotal studies, a series of less visible but highly informative papers addressed mechanisms, complications, patient phenotypes, and unintended consequences of intervention.

This curated selection highlights ten impactful tricuspid...

Alessandro Sticchi

Author

Alessandro Sticchi
The top ten impactful papers on tricuspid intervention we almost missed
Didn’t find what you were looking for?